In a letter dated November 6, 2019, Steve Oldfield, Chief Commercial Officer at the Department of Health and Social Care (DHSC), expresses gratitude to the industry for the high levels of preparation ahead of the October 31, 2019, Brexit deadline. However, he states that the multi-layered approach put in place…

As currently reported in our Brexit Blog, one of the first and most visible consequences of Brexit was EMA’s relocation to the Netherlands. EMA’s seat formally changed from London to Amsterdam on March 30, 2019, but preparatory work for the move started well before that date. From the moment the…

The duty of continuous supply by healthcare manufacturers will continue to apply in the UK following a departure of the UK from the EU without a withdrawal agreement. However, with the risk of interruptions to trade with the EU, the UK government has implemented some additional instructions to ensure that…

The Government has recently imposed restrictions on the parallel export of certain drugs from the UK to the EEA. At the moment, parallel imports tend to flow into the UK, where goods can be bought inexpensively in other EU member states and resold at a higher price in the UK.…